FDA Warns Against Dietary Supplement

By Staff

3/18/2009

US Pharm. 2009;34(3)(Oncology suppl):14.

The FDA warned consumers not to take Venom Hyperdrive 3.0, a dietary supplement containing sibutramine. Sibutramine, a controlled substance with risks of abuse or addiction, is a potent drug that can cause increased blood pressure and heart rate. This poses a significant risk, the agency says, for patients with heart disease, heart failure, irregular heart beats, or stroke.

Venom Hyperdrive 3.0 is marketed by Applied Lifescience Research Industries Inc. (ALR Industries), Oak View, California. In December, ALR Industries recalled all lots of Venom Hyperdrive 3.0 after the FDA's analysis showed samples of sibutramine.

U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Copyright © 2000 - 2013 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.